Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2016-10-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于召开2016年第一次临时股东大会的通知公告
Regulatory Filings Classification · 95% confidence The document is a detailed notice about convening the 2016 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It includes information on meeting date, voting procedures (both onsite and online), agenda items for shareholder approval, registration details, and proxy forms. There is no financial data or report content, only procedural and meeting logistics information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) or a meeting notice. However, since it is a notice of the meeting and voting procedures rather than the voting results, it is best classified as a Regulatory Filing (RNS) because it does not fit the exact DVA category (which requires official voting results). It is not an AGM Information (AGM-R) because it is not an annual meeting but an extraordinary meeting. The document is over 5,000 characters and contains detailed procedural content, so it is not a mere announcement (RPA). Therefore, the best fit is Regulatory Filings (RNS).
2016-10-18 Chinese
第五届监事会第八次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution passed by the Supervisory Board regarding the approval of the company's 2016 third quarter report. It states that the Supervisory Board has reviewed and approved the 2016 Q3 report and confirms its compliance with relevant laws and regulations. The document also mentions that the full 2016 Q3 report is published on an external website and in newspapers, indicating that this document itself is not the report but an announcement about the report's approval and publication. The document length is short (759 characters), and it primarily serves as a formal announcement of the Supervisory Board's resolution rather than containing the actual financial data or detailed report content. Therefore, according to the rules, this is a Regulatory Filing (RNS) as it is an announcement related to the report but not the report itself.
2016-10-18 Chinese
关于第五届董事会第八次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the eighth meeting of the fifth board of directors of 嘉事堂药业股份有限公司. It includes voting results on various proposals such as approval of the 2016 third quarter report, investment proposals, issuance of asset-backed notes, and authorization for the board to handle related matters. The document does not contain the full financial statements or detailed financial data of the 2016 third quarter report but rather states that the report was approved and published elsewhere. The document is primarily a board meeting resolution announcement, not the actual interim/quarterly report itself. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting decisions and approvals.
2016-10-18 Chinese
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring and the continuation of a trading suspension (停牌) due to ongoing negotiations related to issuing shares to purchase assets. It references regulatory compliance with the Shenzhen Stock Exchange listing rules and states that the company will provide updates every five trading days. The document is short (722 characters) and serves as a progress update on a capital market event rather than a full financial report or detailed filing. It does not contain financial statements or detailed financial data, nor is it a final report or earnings release. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2016-10-11 Chinese
停牌公告
Capital/Financing Update Classification · 90% confidence The document is a short announcement regarding the suspension of trading (停牌公告) of the company's stock due to a planned stock issuance for asset purchase. It mentions regulatory compliance and the intention to disclose further information later. The document is only 611 characters long and does not contain any financial statements or detailed financial data. It is an announcement about a capital market event (stock suspension) related to financing activities, but it is not a detailed financing update or report. Given the short length and nature of the announcement, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and stock issuance plans causing trading suspension.
2016-09-27 Chinese
控股股东限售股份上市流通提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding the lifting of restrictions on certain shares held by a controlling shareholder, allowing these shares to become freely tradable on the stock exchange. It details the number of shares affected, the dates of restriction removal, shareholder commitments, and regulatory approvals. The content focuses on share circulation and shareholder commitments rather than financial results, management changes, or regulatory filings. This matches the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements about share issues, stock splits, or capital changes such as lifting share restrictions. The document length is 2211 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is SHA with high confidence.
2016-08-16 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.